ArticleScientific reports2026
Optimized gradient of lyophilized platelet-rich plasma in biomimetic 3D-printed triphasic scaffold based on alginate and gelatin for osteochondral tissue engineering.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study developed a 3D-printed, triphasic (subchondral bone, calcified, and articular cartilage) scaffold using biological macromolecule-based bioinks to support the chondrogenic differentiation of bone marrow-derived mesenchymal stem cells (BM-MSCs). A subchondral bone layer was formed by blending various concentrations of graphene oxide (GO) (1% and 2% w/w) into an alginate (Alg) and gelatin (Gel) bioink, two natural biopolymers known for their biocompatibility and biodegradability. Following mechanical and biocompatibility assessments, the 1% GO concentration was selected and applied consistently through the subchondral and calcified cartilage layers. In contrast, the gradient of lyophilized platelet-rich plasma (PRP) powder was adjusted to 1%, 2%, and 3% (w/v) to more accurately replicate the characteristics of calcified and articular cartilage. Triphasic scaffolds with different PRP gradients were evaluated for water absorption, biodegradability, rheological behavior, stem cell viability, and chondroinductive activity. The results indicated that 3D-printed triphasic scaffolds containing 1% or 2% PRP exhibited favorable biomechanical properties, with no significant differences between the two concentrations. However, scaffolds with 2% PRP facilitated the attachment, proliferation, and survival of BM-MSCs, as indicated by an increase in the expression of cartilage-related genes and enhanced production of glycosaminoglycan (GAG), as confirmed through real-time PCR and Alcian Blue staining, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.